Radiation therapy after surgery for early glottic cancer
Part of Cancer, Ear, nose & throat clinical trials.
This study looks at whether adding radiation therapy after surgery improves outcomes for people with early-stage glottic cancer that involves the anterior commissure (the front part of the vocal cords). If you join, you may receive radiation therapy or not, and the researchers will compare the results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a confirmed diagnosis of glottic squamous cell carcinoma (a type of throat cancer).
- Your cancer is stage T1 or T2 and has not spread to lymph nodes or distant sites (N0M0).
- You have undergone surgery to remove the cancer within the last 4 to 8 weeks, and the margins were negative (no cancer at the edges).
- You have not received prior radiation therapy, chemotherapy, or other anti-cancer treatments.
- You have an ECOG performance status of 0 or 1 (meaning you are fully active or restricted only in physically strenuous activity).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether adding radiation therapy after surgery can help people with early-stage voice box cancer that has poor differentiation (cells look very abnormal). It aims to improve outcomes for this specific type of cancer.
This study tests giving a short course of targeted radiation (SBRT) along with immunotherapy and a targeted drug before surgery for advanced head and neck cancer. The goal is to see if this combination can shrink the tumor and improve outcomes.
This trial tests whether giving radiation after surgery can lower the risk of the cancer coming back for people with oral tongue cancer that has specific high-risk features but not advanced spread. It aims to find the best treatment plan for patients with certain tumor characteristics.
This study compares ways of treating early squamous cell cancer in the tonsil or the tongue base, using either radiation therapy, transoral (through-the-mouth) surgery, or both. It aims to see which approach works best while keeping cancer under control.
This trial tests whether adding radiation therapy after surgery helps prevent the return of early-stage tongue cancer in patients who have certain risk factors, such as nerve invasion or poorly differentiated cells. It is for people whose cancer was limited to the front two-thirds of the tongue and was completely removed.
This trial tests a shorter course of radiation therapy for early-stage vocal cord cancer. The aim is to see if giving slightly higher doses per session (3.5 Gy) is safe and effective.
Hear when a new Early Stage Glottic Squamous Cell Carcinoma Involving the Anterior Commissure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.